Ultragenyx Pharmaceutical Inc. buy Piper Sandler
Start price
17.03.25
/
50%
€35.20
Target price
17.03.26
€105.64
Performance (%)
-12.50%
Price
12.12.25
€30.80
Summary
This prediction is currently active. The prediction for Ultragenyx Pharmaceutical Inc. disappoints with a performance of -12.50%. This prediction currently runs until 17.03.26. The prediction end date can be changed by Piper_Sandler at any time. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ultragenyx Pharmaceutical Inc. | -1.282% | -1.282% |
| iShares Core DAX® | 0.734% | -0.964% |
| iShares Nasdaq 100 | -2.686% | -2.409% |
| iShares Nikkei 225® | -2.261% | -4.038% |
| iShares S&P 500 | -1.346% | -1.510% |
Comments by Piper_Sandler for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) had its price target lowered by analysts at Piper Sandler from $140.00 to $115.00. They now have an "overweight" rating on the stock.
Ratings data for RARE provided by MarketBeat
Stopped prediction by Piper_Sandler for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€41.20
13.01.25
13.01.25
€137.24
13.01.26
13.01.26
-25.24%
12.12.25
12.12.25
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€30.80
25.10.23
25.10.23
€122.98
25.10.24
25.10.24
61.04%
26.10.24
26.10.24